ClinicalTrials.gg
RecruitingNCT04046523ICP WaveformUpdated Nov 12, 2026

Non-Invasive and Non-Contact Intracranial Pressure Waveform Recording Using Dynamic Video Ophthalmoscopy

An interventional study of Video ophthalmoscope in Intracranial Pressure Increase, sponsored by University of Minnesota. Recruiting at 1 site in United States. Open to participants aged 4 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by University of Minnesota · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Started Jan 2023; still recruiting 3 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Non-randomized
Ages
4 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 29 studies in Intracranial Hypertension with a site in United States — 3 open to participants now, 3 under way, none of them phase 3. Intracranial Hypertension · United States.

Planned enrollment
2nd of 15
90 · median 16
Started
2023
the only one that year
No phase
12 of 29
2 open now
Registered
23rd of 29
by date

Among the 29 studies in Intracranial Hypertension with a site in United States, this one is the 2nd largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2023, is one of 12 with no phase, and was the 23rd registered.

Intracranial Hypertension

166 studies on the registry are indexed under Intracranial Hypertension; 37 are open to participants now.

Browse Intracranial Hypertension studies →

Open to participants now

3 of the 29 studies in Intracranial Hypertension with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 23 Intracranial Hypertension studies recruiting now, 11 (48%) set no upper age limit and 5 (22%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.

This study: 4 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Intracranial Hypertension with a site in United States, or all of them as a file.
02

Study summary

This study will test the use of video ophthalmoscope to provide information about intracranial pressure without the use of invasive methods, anesthesia or contact with the eye.

Read the detailed description

The monitoring of intracranial pressure (ICP) is crucial in head injuries and pathologies such as brain edema, arachnoid cyst, craniosynostosis or, in very-low-birthweight infants, post-hemorrhagic hydrocephalus. Some current methods of ICP are invasive and, in the case of lumbar puncture, require anesthesia, which can distort the measurement by 5-10 mmHg. The golden clinical standard is direct measurement using a surgically-implanted intraventricular drain connected to an external pressure transducer ("ICP probe"). However, this method carries risks such as hemorrhage, malfunction, obstruction or infection . The risk in pediatric patients is up to 5% and in adults the risk of fatal hemorrhage is 4-5% in patients with subdural and intraparenchymal monitoring devices. Due to these risks and the financial burden on patients, there have been attempts to develop tools for non-invasive ICP estimation. This study will test the use of a video ophthalmoscope that will calculate the relative waveform of intracranial pressure and provide information about intracranial compliance without the use of anesthesia, invasive methods or contact with the eye.

03

Conditions studied

  • Intracranial Pressure Increase

Keywords

  • video ophthalmoscope
  • intraocular pressure
  • electrocardiogram
  • photoplethysmography
  • retinal pulsatility
  • spontaneous venous pulsation
  • blind source separation
04

Who can participate

Ages eligible
4 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must be able to sit still and fix their eyes on a target in the VO objective.
  • ICP participants must have an inserted ICP probe for clinical purposes.

Exclusion criteria

Exclusion Criteria:

  • Diagnosis of glaucoma, retinopathy or head tremor.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Healthy Controls

    In the first phase of the experiment, 20 healthy controls will test the VO device to determine whether the camera with a CCD or CMOS lens is the most appropriate for use in ICP patients and to synchronize the VO, ECG, PPG, IOP and respiratory signals.

    Device: Video ophthalmoscope

  • Experimental
    Transfer Function Estimation

    Subjects in the second phase of the experiment (70 subjects total) will be randomized to either Group A or Group B. We anticipate that 25 adult and 10 pediatric (ages 4-17) patients will participate in each group. Individuals in Group A will have two inter-leaved examinations (1-14 days apart). Data from the first examination will serve for SVP-ICP transfer function estimation and data from the second examination will serve for the intra-group verification for the estimated transfer function.

    Device: Video ophthalmoscope

  • Experimental
    Intra-Group Verification

    Individuals in Group B will undergo one examination. Data from Group B participants will serve as the inter-group re-test verification of the estimated transfer function.

    Device: Video ophthalmoscope

Interventions

  • DeviceVideo ophthalmoscope

    Use of a custom video ophthalmoscope with either a CCD or CMOS camera lens. The healthy controls group (first 20 subjects) will provide data to help determine which lens might be best for measuring ICP patients (Groups A and B) in the second phase of the study.

06

What researchers measure

Primary outcomes

  1. The study will look at whether retinal video-recordings can be used to help estimate intracranial pressure.

    This study will help determine whether there could be a less invasive method of monitoring intracranial pressure. It is thought that the use of a video-ophthalmoscope recordings could be utilized to measure intracranial pressure. The outcome measures will be provided as z-scores.

    Time frame: Participants in the Healthy Control and Intra-Group Verification arms will be enrolled for one day. Transfer Function Estimation Subjects will be enrolled for up to 14 days.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2023 (actual). Primary completion is estimated for Jul 2029, 78 months after the start.

Of 37 non-industry interventional studies with no phase under Intracranial Hypertension, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 39. This study's planned 78 months is above that.

Counting every sponsor, half of 38 studies reached it within 18 months; a quarter within 6 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2019
First posted
Aug 6, 2019
StartActual
Jan 31, 2023
Primary completionEst.
Jul 31, 2029
CompletionEst.
Jul 31, 2030
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date
1 update, last Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Minor edits only
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04046523
Collaborators
Hennepin County Medical Center, Minneapolis, Minnesota Office of Higher Education
Responsible party
Sponsor
First posted
Aug 6, 2019
Start date
Jan 31, 2023
Primary completion
Jul 31, 2029 (estimated)
Completion
Jul 31, 2030 (estimated)
Last update
Nov 12, 2026

Study contacts

Igor Nestrasil, MD, PhD
Contact
nestr007@umn.edu
612-625-0496
Igor Nestrasil, MD, PhD
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion